Drug Profile
Research programme: GABA A-alpha2 receptor modulators - Neurion
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Neurion Pharmaceuticals
- Class Small molecules
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Anxiety-disorders in USA
- 20 Jun 2005 Preclinical trials in Anxiety disorders in USA (unspecified route)